[CAS NO. 150-38-9]??Ethylenediaminetetraacetic acid trisodium salt
Please click "REQUEST A QUOTE" button if you need other sizes or
custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis,
please:
PRODUCTS SPECIFICATIONS [150-38-9]
Catalog
HY-B1009
Brand
MCE
CAS
150-38-9
DESCRIPTION [150-38-9]
Overview
| MDL | MFCD00013305 |
|---|---|
| Molecular Weight | 358.19 |
| Molecular Formula | C10H13N2Na3O8 |
| SMILES | O=C(O)CN(CCN(CC(O[Na])=O)CC(O[Na])=O)CC(O[Na])=O |
For research use only. We do not sell to patients.
5 Publications Citing Use of MCE
Summary
Ethylenediaminetetraacetic acid trisodium salt (EDTA trisodium salt) is used to bind metal ions in the practice of chelation therapy, for treating mercury and lead poisoning, used in a similar manner to remove excess iron from the body, for treating the complication of repeated blood transfusions, as would be applied to treat thalassaemia.
Clinical Trial
| NCT Number | Sponsor | Condition | Start Date | Phase |
|---|---|---|---|---|
| NCT04310254 | Istanbul Medipol University Hospital |
Postoperative Pain|Endodontically Treated Teeth
|
September 1, 2019 | Not Applicable |
| NCT04067245 | University Health Network, Toronto |
Catheter Complications
|
April 1, 2019 | Not Applicable |
| NCT05170932 | Ain Shams University |
Periodontal Bone Loss
|
January 2017 | Not Applicable |
| NCT04893577 | University of Utah |
Herpes Simplex Oral
|
January 20, 2022 | Phase 2 |
| NCT00044213 | Mt. Sinai Medical Center, Miami|National Heart, Lung, and Blood Institute (NHLBI)|National Center for Complementary and Integrative Health (NCCIH) |
Coronary Artery Disease
|
September 2003 | Phase 3 |
| NCT02714075 | Swiss Federal Institute of Technology|University for Development Studies, Tamale, Ghana |
Iron Deficiency and+or Anemia
|
April 2016 | Not Applicable |
| NCT03336970 | Mehmet Kemal ?al??kan|Ege University |
Root Canal Infection
|
January 1, 2011 | Not Applicable |
| NCT04559334 | Boston Children′s Hospital|SterileCare Inc. |
Central Line Complication|Central Line-associated Bloodstream Infection (CLABSI)
|
December 21, 2020 | Not Applicable |
| NCT03419429 | Ain Shams University |
Chronic Periodontitis
|
January 2016 | Phase 4 |
| NCT02286258 | Assistance Publique - H?pitaux de Paris|Ministry of Health, France |
Renal Insufficiency, Chronic|Kidney Diseases
|
October 2014 | Phase 1|Phase 2 |
| NCT01118663 | Cumberland Pharmaceuticals |
Acetaminophen Overdose
|
September 2010 | Phase 3 |
| NCT03424746 | Mt. Sinai Medical Center, Miami |
Critical Limb Ischemia|Peripheral Arterial Disease
|
August 2015 | Early Phase 1 |
| NCT03853200 | Dow University of Health Sciences |
Endodontic Disease|Root Canal Infection
|
April 3, 2017 | Phase 2|Phase 3 |
| NCT04044417 | Ain Shams University |
Periodontitis
|
August 25, 2016 | Phase 4 |
| NCT00227409 | Chang Gung Memorial Hospital |
Urologic Disease
|
November 2001 | Not Applicable |
| NCT00237952 | Chang Gung Memorial Hospital |
Diabetic Nephropathies|Diabetes Mellitus, Type II
|
August 2005 | Not Applicable |
| NCT04980066 | Kafrelsheikh University |
Gingival Recession
|
August 3, 2021 | Not Applicable |
| NCT02733185 | Mt. Sinai Medical Center, Miami|National Center for Complementary and Integrative Health (NCCIH)|National Heart, Lung, and Blood Institute (NHLBI)|Duke Clinical Research Institute |
Diabetes|Myocardial Infarction
|
October 2016 | Phase 3 |
| NCT04154553 | University Hospital, Basel, Switzerland|Toppharm Apotheke Hersberger, Spalenberg 41, CH-4051 Basel |
Adverse Drug Reaction|Therapy Failure
|
October 15, 2019 | |
| NCT05064462 | Assistance Publique - H?pitaux de Paris|BioMérieux |
Heart Transplant Rejection|Heart Transplant Infection|Virus
|
March 3, 2022 | |
| NCT00757458 | University of Sao Paulo|AstraZeneca |
Drug Contamination
|
December 2008 | Not Applicable |
| NCT01950975 | Centre Hospitalier Universitaire Dijon |
Malformations With Skin Manifestations Suggesting Mosaicism
|
Not Applicable | |
| NCT03985371 | University of Rochester|Livionex Inc |
Corneal Dystrophy, Band-Shaped
|
June 29, 2020 | Early Phase 1 |
| NCT03253393 | The University of New South Wales|Menicon Co., Ltd. |
Optometry
|
June 4, 2018 | Not Applicable |
| NCT04786327 | Tanta University |
Periodontal Regeneration
|
January 1, 2018 | Phase 2 |
| NCT04548713 | Fraser Health|SterileCare Inc.|Center for Health Evaluation & Outcome Services |
Central Venous Catheter Thrombosis|Central Venous Catheter Related Bloodstream Infection|Catheter Complications|Catheter Blockage|Catheter Dysfunction|Central Line-associated Bloodstream Infection (CLABSI)|Catheter|Catheter Infection
|
March 22, 2022 | Not Applicable |
Appearance
Solid
Shipping
Room temperature in continental US; may vary elsewhere.
Storage
4°C, sealed storage, away from moisture
* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
Solvent & Solubility
In Vitro:
H 2 O : 50 mg/mL ( 139.59 mM ; Need ultrasonic)
Preparing
Stock Solutions
Stock Solutions
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 2.7918 mL | 13.9591 mL | 27.9181 mL |
| 5 mM | 0.5584 mL | 2.7918 mL | 5.5836 mL |
| 10 mM | 0.2792 mL | 1.3959 mL | 2.7918 mL |
*
Please refer to the solubility information to select the appropriate solvent.
In Vivo:
-
1.
Add each solvent one by one: PBS
Solubility: 50 mg/mL (139.59 mM); Clear solution; Need ultrasonic
*
All of the co-solvents are available by MCE.
Synonyms
Glycine, N,N′-1,2-ethanediylbis[N-(carboxymethyl)-, sodium salt (1:3)
Acetic acid, (ethylenedinitrilo)tetra-, trisodium salt
Glycine, N,N′-1,2-ethanediylbis[N-(carboxymethyl)-, trisodium salt
EDTA trisodium salt
Perma Kleer 50, trisodium salt
Sequestrene trisodium
Sequestrene trisodium salt
Trilon AO
Trisodium edetate
Trisodium hydrogen ethylenediaminetetraacetate
Trisodium hydrogen (ethylenedinitrilo)tetraacetate
Trisodium versenate
Versene 9
Ethylenediaminetetraacetic acid trisodium salt
Nevanaid-B powder
Trisodium ethylenediaminetetraacetate
Sequestrene Na3
Edetate trisodium
Trisodium EDTA
Clewat 300A
Trisodium ETDA
Chelest C
Limclair
Sequestrene NA 3T
EDTA-3Na
Chelest 2CS
Chelate C
Zonon T
Chelest 2C-SD
Clewat 3Na
EDTA trisodium
Powered by Arctom Copyright ? 2026 Arctom.
All rights reserved.